Related Experiment Video
Updated: Jan 3, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Microphthalmia family of transcription factors associated renal cell carcinoma
Ling Xie1,2, Yifen Zhang1, Chin-Lee Wu2
1Department of Pathology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Abstract:
The microphthalmia (MiT) subfamily of transcription factors includes TFE3, TFEB, TFEC, and MITF. In the 2016 World Health Organization classification, MiT family translocation renal cell carcinoma (tRCC) including Xp11 tRCC and t(6;11) RCC, was newly defined as an RCC subtype. Xp11 and t(6;11) RCC are characterized by the rearrangement of the MiT transcription factors TFE3 and TFEB, respectively. Recent studies identified the fusion partner-dependent clinicopathological and immunohistochemical features in TFE3-rearranged RCC. Furthermore, RCC with TFEB amplification, melanotic MiT family translocation neoplasms, was identified may as a unique subtype of MiT family associated renal neoplasms, along with MITF associated RCC. In this review, we will collect available literature of these newly-described RCCs, analyze their clinicopathological and immunohistochemical features, and summarize their molecular and genetic evidences. We expect this review would be beneficial for the understanding of these rare subtypes of RCCs, and eventually promote clinical management strategies.
Insights
This review details rare kidney cancer subtypes, focusing on MiT family translocation renal cell carcinoma (tRCC) involving TFE3 and TFEB gene rearrangements. Understanding these rare renal neoplasms aids clinical management.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- The microphthalmia (MiT) transcription factor family includes TFE3, TFEB, TFEC, and MITF.
- MiT family translocation renal cell carcinoma (tRCC), including Xp11 and t(6;11) subtypes, was newly defined in the 2016 WHO classification.
- These RCC subtypes are characterized by specific gene rearrangements involving TFE3 or TFEB.
Purpose of the Study:
- To review and analyze newly described MiT family-associated renal neoplasms.
- To consolidate clinicopathological, immunohistochemical, and molecular/genetic data for these rare RCC subtypes.
- To enhance understanding and inform clinical management strategies for these rare renal tumors.
Main Methods:
- Literature review of available studies on MiT family-associated renal neoplasms.
- Analysis of clinicopathological and immunohistochemical features.
- Summary of molecular and genetic evidence, including gene fusions and amplifications.
Main Results:
- Identification of distinct clinicopathological and immunohistochemical features dependent on fusion partners in TFE3-rearranged RCC.
- Recognition of TFEB-amplified RCC and melanotic MiT family translocation neoplasms as unique subtypes.
- Association of MITF with a distinct category of renal neoplasms.
Conclusions:
- MiT family transcription factors play a crucial role in the pathogenesis of specific renal cell carcinoma subtypes.
- Detailed characterization of these rare RCCs is essential for accurate diagnosis and treatment.
- This review provides a comprehensive overview to support clinical decision-making for patients with MiT family-associated renal neoplasms.
Related Concept Videos
Master Transcription Regulators
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
General Transcription Factors

